Table 2.
Action | Ligand | Effects on immune cells | References |
---|---|---|---|
Natural agonist | DHA, EPA | ↓ proliferation, migration, IL-2, IFN-γ, IL-17, IL-10, NF-κB, PKC; ↑ calcium, PPAR, apoptosis, ROS in T-cells. | Verlengia et al., 2004; Denys et al., 2005; Yessoufou et al., 2009; Unoda et al., 2013; Zhelev et al., 2016; Cucchi et al., 2020; Saidi et al., 2020 |
↑ phagocytosis, TNF-α, IL-1β, MMP-9, ROS, calcium; ↓ IL-8, ROS, calcium and NF-κB in neutrophils. | Fickl et al., 2005; Gorjao et al., 2006; Pisani et al., 2009; Paschoal et al., 2013; Olmo et al., 2019 | ||
↓ HDACs, Inflammasome, IL-1, TAK1, MKK4, NF-κB, p38 MAPK, ERK, JNK;↑ M2 macrophages. | Rahman et al., 2008; Oh et al., 2010; Xue et al., 2012; Li et al., 2013; Pham et al., 2018; Kasonga et al., 2019; Kawano et al., 2019; Wierenga et al., 2019 | ||
Synthetic agonist | TUG-891 | ↑ calcium, MMP-9 and ROS in neutrophils. | Olmo et al., 2019 |
↑ M2 markers; ↓ M1 markers, motility and phagocytosis in macrophages. | Hudson et al., 2013; Wang et al., 2019a; Zhao et al., 2019; Su et al., 2020 | ||
Grifolic acid | ↓ viability, ATP and MMP in macrophages. | Zhao et al., 2018 | |
GSK 137647 | ↓ MMP-9, MMP-3, TIMP-1 and migration in macrophages. | Hasan et al., 2017 | |
Compound A | ↓ NF-κB, TNF-α, IL-6 and chemotaxis, in macrophages. | Oh et al., 2014 | |
KDT501 | ↓ IL-6, IL-10, MCP-1 and RANTES in macrophages. | Konda et al., 2014 | |
Antagonist | AH7614 | ↓ Calcium and ROS in neutrophils. | Olmo et al., 2019 |
↑, increases; ↓, decreases.